218 related articles for article (PubMed ID: 30786708)
1. Determinants of Orexin Receptor Binding and Activation-A Molecular Dynamics Study.
Karhu L; Magarkar A; Bunker A; Xhaard H
J Phys Chem B; 2019 Mar; 123(12):2609-2622. PubMed ID: 30786708
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA.
Suno R; Kimura KT; Nakane T; Yamashita K; Wang J; Fujiwara T; Yamanaka Y; Im D; Horita S; Tsujimoto H; Tawaramoto MS; Hirokawa T; Nango E; Tono K; Kameshima T; Hatsui T; Joti Y; Yabashi M; Shimamoto K; Yamamoto M; Rosenbaum DM; Iwata S; Shimamura T; Kobayashi T
Structure; 2018 Jan; 26(1):7-19.e5. PubMed ID: 29225076
[TBL] [Abstract][Full Text] [Related]
3. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation.
Hong C; Byrne NJ; Zamlynny B; Tummala S; Xiao L; Shipman JM; Partridge AT; Minnick C; Breslin MJ; Rudd MT; Stachel SJ; Rada VL; Kern JC; Armacost KA; Hollingsworth SA; O'Brien JA; Hall DL; McDonald TP; Strickland C; Brooun A; Soisson SM; Hollenstein K
Nat Commun; 2021 Feb; 12(1):815. PubMed ID: 33547286
[TBL] [Abstract][Full Text] [Related]
4. Computational studies on horseshoe shape pocket of human orexin receptor type 2 and boat conformation of suvorexant by molecular dynamics simulations.
Bai Q; Pérez-Sánchez H; Shi Z; Li L; Shi D; Liu H; Yao X
Chem Biol Drug Des; 2018 Jul; 92(1):1221-1231. PubMed ID: 29450984
[TBL] [Abstract][Full Text] [Related]
5. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.
Yin J; Babaoglu K; Brautigam CA; Clark L; Shao Z; Scheuermann TH; Harrell CM; Gotter AL; Roecker AJ; Winrow CJ; Renger JJ; Coleman PJ; Rosenbaum DM
Nat Struct Mol Biol; 2016 Apr; 23(4):293-9. PubMed ID: 26950369
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.
Yin J; Mobarec JC; Kolb P; Rosenbaum DM
Nature; 2015 Mar; 519(7542):247-50. PubMed ID: 25533960
[TBL] [Abstract][Full Text] [Related]
7. Structure-based development of a subtype-selective orexin 1 receptor antagonist.
Hellmann J; Drabek M; Yin J; Gunera J; Pröll T; Kraus F; Langmead CJ; Hübner H; Weikert D; Kolb P; Rosenbaum DM; Gmeiner P
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):18059-18067. PubMed ID: 32669442
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
Rappas M; Ali AAE; Bennett KA; Brown JD; Bucknell SJ; Congreve M; Cooke RM; Cseke G; de Graaf C; Doré AS; Errey JC; Jazayeri A; Marshall FH; Mason JS; Mould R; Patel JC; Tehan BG; Weir M; Christopher JA
J Med Chem; 2020 Feb; 63(4):1528-1543. PubMed ID: 31860301
[TBL] [Abstract][Full Text] [Related]
9. Modeling of the OX1R-orexin-A complex suggests two alternative binding modes.
Karhu L; Turku A; Xhaard H
BMC Struct Biol; 2015 May; 15():9. PubMed ID: 25957175
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist.
Beuckmann CT; Suzuki M; Ueno T; Nagaoka K; Arai T; Higashiyama H
J Pharmacol Exp Ther; 2017 Aug; 362(2):287-295. PubMed ID: 28559480
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands.
Turku A; Borrel A; Leino TO; Karhu L; Kukkonen JP; Xhaard H
J Med Chem; 2016 Sep; 59(18):8263-75. PubMed ID: 27546834
[TBL] [Abstract][Full Text] [Related]
12. Investigation of New Orexin 2 Receptor Modulators Using
Janockova J; Dolezal R; Nepovimova E; Kobrlova T; Benkova M; Kuca K; Konecny J; Mezeiova E; Melikova M; Hepnarova V; Ring A; Soukup O; Korabecny J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30423961
[TBL] [Abstract][Full Text] [Related]
13. Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis.
Heifetz A; Barker O; Morris GB; Law RJ; Slack M; Biggin PC
Biochemistry; 2013 Nov; 52(46):8246-60. PubMed ID: 24144388
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor.
Gunera J; Baker JG; van Hilten N; Rosenbaum DM; Kolb P
J Med Chem; 2020 Oct; 63(19):11045-11053. PubMed ID: 32977721
[TBL] [Abstract][Full Text] [Related]
15. The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia.
Coleman PJ; Gotter AL; Herring WJ; Winrow CJ; Renger JJ
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():509-533. PubMed ID: 27860547
[TBL] [Abstract][Full Text] [Related]
16. Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation.
Vitale RM; Iannotti FA; Schiano Moriello A; Tunisi L; Piscitelli F; Savopoulos R; Cristino L; De Petrocellis L; Amodeo P; Gray R; Di Marzo V
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439801
[TBL] [Abstract][Full Text] [Related]
17. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors.
Palus K; Chrobok L; Lewandowski MH
Neuroscience; 2015 Aug; 300():370-80. PubMed ID: 26022361
[TBL] [Abstract][Full Text] [Related]
18. Oxadiazole Derivatives as Dual Orexin Receptor Antagonists: Synthesis, Structure-Activity Relationships, and Sleep-Promoting Properties in Rats.
Brotschi C; Roch C; Gatfield J; Treiber A; Williams JT; Sifferlen T; Heidmann B; Jenck F; Bolli MH; Boss C
ChemMedChem; 2019 Jul; 14(13):1257-1270. PubMed ID: 31066976
[TBL] [Abstract][Full Text] [Related]
19. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
Tsuneki H; Wada T; Sasaoka T
Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
[TBL] [Abstract][Full Text] [Related]
20. Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties.
Kuduk SD; Skudlarek JW; DiMarco CN; Bruno JG; Pausch MH; O'Brien JA; Cabalu TD; Stevens J; Brunner J; Tannenbaum PL; Garson SL; Savitz AT; Harrell CM; Gotter AL; Winrow CJ; Renger JJ; Coleman PJ
Bioorg Med Chem Lett; 2015 Jun; 25(12):2488-92. PubMed ID: 25981685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
